This is a single arm, single centre, investigator initiated study to investigate the use of
FAZA-PET in combination with MRI. FAZA is an investigational radiotracer used in PET scans.
FAZA PET-MRI will be used to measure hypoxia in up to 20 patients with unresectable,
non-metastatic, locally advanced un-resectable pancreatic adenocarcinoma (LAPAC).
After each FAZA PET-MRI scan, patients will be followed up via telephone, 48 hours after the
imaging session to assure that the procedure was tolerated without side effects. Patients
will undergo a FAZA PET-MRI scans before and after their standard of care radiation
treatment.